famotidine has been researched along with pentagastrin in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (24.00) | 18.7374 |
| 1990's | 10 (40.00) | 18.2507 |
| 2000's | 2 (8.00) | 29.6817 |
| 2010's | 7 (28.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bräuer, U; Kromer, W; Postius, S | 1 |
| Inatomi, N; Nagaya, H; Satoh, H | 1 |
| Igata, H; Nishida, T; Okabe, S; Takagi, K | 1 |
| Chremos, AN; Gamal, MA; Graham, DY; Smith, JL | 1 |
| Chremos, AN; Huber, PB; Kuljian, B; McCallum, RW; Tupy-Visich, MA | 1 |
| Smith, JL | 1 |
| Burget, DW; Chremos, AN; De Gara, CJ; Hunt, RH; Silletti, C | 1 |
| Maeno, H; Takagi, T; Takeda, M | 1 |
| Dammann, HG; Feurle, G; Lichtwald, K; Müller, P; Schmidt-Gayk, H; Simon, B | 1 |
| Haga, N; Itoh, Z; Matsunaga, Y; Sano, I; Shiba, Y; Yamamoto, O | 1 |
| Black, JW; Gerskowitch, VP; Harper, EA; Hull, RA; Roberts, SP; Shankley, NP; Watt, GF | 1 |
| Cottrell, J; Grimley, CE; Loft, DE; Mann, SG; Nwokolo, CU; Stauffer, L; West, JM | 1 |
| Black, JW; Gerskowitch, VP; Hills, DM; Roberts, SP; Shankley, NP; Welsh, NJ | 1 |
| Akuzawa, S; Ito, H; Miyake, A; Miyata, K; Nishida, A; Takemoto, Y; Takinami, Y; Yuki, H | 1 |
| Arai, H; Inoie, M; Marubuchi, S | 1 |
| Martin, P; McKeand, W; Ohning, G; Paul, J; Pisegna, JR; Walsh, JH | 1 |
| Horie, S; Maruyama, T; Ochi, Y; Watanabe, K; Yano, S | 1 |
| Badawy, SI; Gray, DB; Hussain, MA; Schuster, AE; Sun, D; Zhao, F | 1 |
| Derbin, G; Fancher, RM; Marathe, P; Rockar, R; Sleczka, B; Zhang, H | 1 |
| Beauchamp, M; Chiti, F; Kesisoglou, F; Mitra, A; Wu, Y; Zhu, W | 1 |
| Hirata, T; Keto, Y; Takemoto, Y; Yamano, M; Yokoyama, T | 1 |
| Chen, JZ; Coraggio, M; Hau, J; Imperio, J; Liu, L; Lubach, JW; Wong, H | 1 |
| Dalziel, G; Dean, B; Pang, J; Salphati, L; Ware, JA | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
1 review(s) available for famotidine and pentagastrin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
5 trial(s) available for famotidine and pentagastrin
| Article | Year |
|---|---|
MK-208, a novel histamine H2-receptor inhibitor with prolonged antisecretory effect.
Topics: Adult; Cimetidine; Famotidine; Gastric Acid; Gastric Juice; Gastric Mucosa; Histamine H2 Antagonists; Humans; Hydrogen-Ion Concentration; Middle Aged; Pentagastrin; Thiazoles | 1985 |
The effects of intravenous famotidine on pentagastrin-stimulated gastric secretion in man.
Topics: Adult; Double-Blind Method; Famotidine; Gastric Acid; Humans; Infusions, Intravenous; Pentagastrin; Reference Values | 1987 |
[Human acid secretion during daily administration of H2-blockers].
Topics: Adult; Clinical Trials as Topic; Famotidine; Gastric Acid; Humans; Male; Pentagastrin; Random Allocation; Ranitidine; Thiazoles | 1984 |
Early and late effects of low-dose famotidine, ranitidine or placebo on pentagastrin-stimulated gastric acid secretion in man.
Topics: Administration, Oral; Adult; Analysis of Variance; Anti-Ulcer Agents; Cross-Over Studies; Famotidine; Female; Gastric Acid; Helicobacter pylori; Histamine H2 Antagonists; Humans; Infusions, Intravenous; Male; Middle Aged; Pentagastrin; Peptic Ulcer; Ranitidine; Treatment Outcome | 1996 |
Inhibition of pentagastrin-induced gastric acid secretion by intravenous pantoprazole: a dose-response study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Anti-Ulcer Agents; Benzimidazoles; Dose-Response Relationship, Drug; Famotidine; Female; Gastric Acid; Humans; Infusions, Intravenous; Male; Middle Aged; Omeprazole; Pantoprazole; Pentagastrin; Proton Pump Inhibitors; Sulfoxides; Zollinger-Ellison Syndrome | 1999 |
19 other study(ies) available for famotidine and pentagastrin
| Article | Year |
|---|---|
The novel proton pump inhibitor pantoprazole elevates intragastric pH for a prolonged period when administered under conditions of stimulated gastric acid secretion in the gastric fistula dog.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenosine Triphosphatases; Animals; Benzimidazoles; Dogs; Famotidine; Gastric Acid; Gastric Fistula; Gastric Mucosa; Male; Omeprazole; Pantoprazole; Pentagastrin; Stomach; Sulfoxides | 1991 |
Differences in the antisecretory actions of the proton pump inhibitor AG-1749 (lansoprazole) and the histamine H2-receptor antagonist famotidine in rats and dogs.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Ulcer Agents; Bethanechol Compounds; Dogs; Famotidine; Female; Gastric Acid; Gastric Mucosa; Histamine; Hydrogen-Ion Concentration; Lansoprazole; Male; Omeprazole; Pentagastrin; Peptones; Pylorus; Rats; Rats, Inbred Strains | 1991 |
[Effects of IT-066, a new histamine H2-receptor antagonist, on gastric acid secretion and experimental gastric ulcers in rats and dogs].
Topics: Acetates; Animals; Anti-Ulcer Agents; Carbachol; Depression, Chemical; Dogs; Famotidine; Female; Gastric Acid; Histamine Antagonists; Histamine H2 Antagonists; Male; Pentagastrin; Piperidines; Pyridines; Rats; Rats, Inbred Strains; Stomach Ulcer | 1990 |
Famotidine, a new H2-receptor antagonist. Effect on parietal, nonparietal, and pepsin secretion in man.
Topics: Adult; Cimetidine; Famotidine; Gastric Acidity Determination; Gastric Juice; Histamine H2 Antagonists; Humans; Male; Parietal Cells, Gastric; Pentagastrin; Pepsin A; Thiazoles; Time Factors | 1985 |
Clinical pharmacology of famotidine.
Topics: Animals; Cimetidine; Circadian Rhythm; Dogs; Dose-Response Relationship, Drug; Duodenal Ulcer; Famotidine; Food; Gastric Acid; Half-Life; Histamine; Histamine H2 Antagonists; Humans; Kinetics; Pentagastrin; Pepsin A; Prolactin; Rats; Tetragastrin; Thiazoles; Time Factors | 1985 |
Kinetics of antisecretory action of a new H2-antagonist, YM-11170, in conscious dogs.
Topics: Animals; Atropine; Cimetidine; Dimaprit; Dogs; Famotidine; Gastric Acid; Gastric Mucosa; Histamine H2 Antagonists; Kinetics; Male; Methacholine Chloride; Methacholine Compounds; Pentagastrin; Thiazoles; Thiourea | 1983 |
Inhibition of motilin-induced phase III contractions by pentagastrin in Heidenhain pouch dogs.
Topics: Animals; Benzodiazepinones; Devazepide; Dogs; Famotidine; Gastric Acidity Determination; Motilin; Muscle Contraction; Pentagastrin; Receptors, Cholecystokinin; Sincalide; Stomach | 1994 |
Analysis of the variation in the action of L-365,260 at CCKB/gastrin receptors in rat, guinea-pig and mouse isolated gastric tissue assays.
Topics: Animals; Benzodiazepinones; Binding, Competitive; Famotidine; Gastric Mucosa; Guinea Pigs; Histamine; Histamine H2 Antagonists; In Vitro Techniques; Mice; Muscle, Smooth; Pentagastrin; Phenylurea Compounds; Rats; Rats, Wistar; Receptors, Cholecystokinin; Species Specificity; Stomach | 1996 |
Pharmacological analysis of the CCKB/gastrin receptors mediating pentagastrin-stimulated gastric acid secretion in the isolated stomach of the immature rat.
Topics: Animals; Binding, Competitive; Enterochromaffin Cells; Famotidine; Gastric Acid; Gastric Mucosa; Histamine; Histamine H2 Antagonists; In Vitro Techniques; Kinetics; Models, Biological; Pentagastrin; Rats; Rats, Wistar; Receptors, Cholecystokinin; Stimulation, Chemical | 1996 |
YM022, a potent and selective gastrin/CCK-B receptor antagonist, inhibits peptone meal-induced gastric acid secretion in Heidenhain pouch dogs.
Topics: Animals; Atropine; Benzodiazepines; Benzodiazepinones; Devazepide; Dogs; Dose-Response Relationship, Drug; Eating; Famotidine; Gastric Acid; Histamine; Histamine H2 Antagonists; Hormone Antagonists; Male; Methacholine Chloride; Muscarinic Antagonists; Pentagastrin; Peptones; Phenylurea Compounds; Receptors, Cholecystokinin; Sincalide; Stomach | 1997 |
Histamine H2-receptor antagonism of T-593, an anti-ulcer agent: studies on aminopyrine accumulation in isolated canine gastric mucosal cells.
Topics: Aminopyrine; Animals; Anti-Ulcer Agents; Bucladesine; Carbachol; Carbon Radioisotopes; Cholinergic Agonists; Dogs; Dose-Response Relationship, Drug; Famotidine; Gastric Acid; Gastric Mucosa; Guanidines; Histamine; Histamine H2 Antagonists; Omeprazole; Pentagastrin; Pirenzepine; Ranitidine; Sulfones | 1998 |
Necessity of intracellular cyclic AMP in inducing gastric acid secretion via muscarinic M3 and cholecystokinin2 receptors on parietal cells in isolated mouse stomach.
Topics: Analysis of Variance; Animals; Benzodiazepines; Bethanechol; Calcium; Cyclic AMP; Dose-Response Relationship, Drug; Famotidine; Gastric Acid; Histamine H2 Antagonists; Male; Mice; Parietal Cells, Gastric; Pentagastrin; Receptor, Cholecystokinin B; Receptor, Muscarinic M3 | 2005 |
Formulation of solid dosage forms to overcome gastric pH interaction of the factor Xa inhibitor, BMS-561389.
Topics: Animals; Biological Availability; Chemistry, Pharmaceutical; Dogs; Drug Interactions; Excipients; Factor Xa Inhibitors; Famotidine; Gastric Acid; Gastrointestinal Agents; Gastrointestinal Tract; Histamine H2 Antagonists; Hydrogen-Ion Concentration; Intestinal Absorption; Isoxazoles; Pentagastrin; Povidone; Pyrazoles; Solubility; Tablets | 2006 |
Development of a canine model to enable the preclinical assessment of pH-dependent absorption of test compounds.
Topics: Administration, Oral; Animals; Dietary Fats; Dogs; Drug Evaluation, Preclinical; Famotidine; Fasting; Gastric Juice; Gastric Mucosa; Gastrostomy; Hydrogen-Ion Concentration; Injections, Intramuscular; Intestinal Absorption; Male; Models, Animal; Pentagastrin; Pharmaceutical Preparations; Pharmacokinetics; Stomach; Time Factors | 2011 |
Using absorption simulation and gastric pH modulated dog model for formulation development to overcome achlorhydria effect.
Topics: Achlorhydria; Animals; Chemistry, Pharmaceutical; Dogs; Famotidine; Humans; Hydrogen-Ion Concentration; Intestinal Absorption; Male; Models, Biological; Pentagastrin; Solubility | 2011 |
Influence of gastric acid on gastric emptying and gastric distension-induced pain response in rats--effects of famotidine and mosapride.
Topics: Abdominal Pain; Animals; Anti-Ulcer Agents; Behavior, Animal; Benzamides; Dose-Response Relationship, Drug; Famotidine; Gastric Acid; Gastric Emptying; Gastrointestinal Motility; Male; Morpholines; Pain Measurement; Pentagastrin; Rats; Rats, Sprague-Dawley; Stomach | 2012 |
Investigation of the rat model for preclinical evaluation of pH-dependent oral absorption in humans.
Topics: Administration, Oral; Animals; Dasatinib; Famotidine; Humans; Hydrogen-Ion Concentration; Ketoconazole; Male; Mefenamic Acid; Pentagastrin; Pyrimidines; Rats; Rats, Sprague-Dawley; Solubility; Thiazoles | 2013 |
Pharmacokinetics and absorption of the anticancer agents dasatinib and GDC-0941 under various gastric conditions in dogs--reversing the effect of elevated gastric pH with betaine HCl.
Topics: Absorption; Achlorhydria; Animals; Antineoplastic Agents; Betaine; Dasatinib; Dogs; Famotidine; Gastric Mucosa; Hydrogen-Ion Concentration; Indazoles; Male; Pentagastrin; Proton Pump Inhibitors; Pyrimidines; Stomach; Sulfonamides; Thiazoles | 2013 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |